Azadeh Golipour - 01 Feb 2024 Form 4 Insider Report for AVROBIO, Inc. (TECX)

Role: Chief Technology Officer
Signature: /s/ Steven Avruch, Attorney in Fact for Azadeh Golipour
Issuer symbol: TECX
Transactions as of: 01 Feb 2024
Net transactions value: -$14,698
Form type: 4
Filing time: 05 Feb 2024, 20:01:02 UTC
Previous filing: 13 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AVRO	Common Stock	Options Exercise	$0	+37,334	+121%	$0.000000	68,104	01 Feb 2024	Direct
transaction	AVRO	Common Stock	Tax liability	$14,698	-12,232	-18%	$1.20	55,872	05 Feb 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AVRO	Restricted Stock Unit	Options Exercise	$0	-37,334	-25%	$0.000000	111,999	01 Feb 2024	Common Stock	37,334	$0.000000	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 10, 2021, the filer was granted 36,344 RSUs. 50% of the shares vested on the second anniversary of the grant date and the remaining 50% vest on the third anniversary of the grant date. This balance includes 18,172 unvested shares.
F2	The shares subject to the RSU shall vest over 4 years, with 25% vesting annually on each anniversary of the Vesting Commencement Date of February 1, 2023.